CSBR

Champions Oncology, Inc.

7.41

USD

CSBR Earnings Reports

Positive Surprise Ratio

CSBR beat 17 of 31 last estimates.

55%

Next Report

Date of Next Report

Mar 09, 2026

Estimate for Q3 26 (Revenue/ EPS)

$16.95M

$0.09

Implied change from Q2 26 (Revenue/ EPS)

+12.67%

+350.00%

Implied change from Q3 25 (Revenue/ EPS)

-0.55%

-75.00%

Champions Oncology, Inc. earnings per share and revenue

On Dec 15, 2025, CSBR reported earnings of 0.02 USD per share (EPS) for Q2 26, beating the estimate of 0.01 USD, resulting in a 96.08% surprise. Revenue reached 15.04 million, compared to an expected 14.32 million, with a 5.01% difference. The market reacted with a -13.72% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 3 analysts forecast an EPS of 0.09 USD, with revenue projected to reach 16.95 million USD, implying an increase of 350.00% EPS, and increase of 12.67% in Revenue from the last quarter.

FAQ

What were Champions Oncology, Inc.'s earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Champions Oncology, Inc. reported EPS of $0.02, beating estimates by 96.08%, and revenue of $15.04M, 5.01% above expectations.

How did the market react to Champions Oncology, Inc.'s Q2 2026 earnings?

The stock price moved down -13.72%, changed from $7.80 before the earnings release to $6.73 the day after.

When is Champions Oncology, Inc. expected to report next?

The next earning report is scheduled for Mar 09, 2026.

What are the forecasts for Champions Oncology, Inc.'s next earnings report?

Based on 3 analysts, Champions Oncology, Inc. is expected to report EPS of $0.09 and revenue of $16.95M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.